Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Stockholders Equity of $139.07 million for fiscal year 2025.
RHYTHM PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $139.07M | +540.0% |
| 2024 | $21.73M | -87.2% |
| 2023 | $169.76M | -35.8% |
| 2022 | $264.26M | -7.0% |
| 2021 | $284.15M | +70.6% |
| 2020 | $166.53M | -40.7% |
| 2019 | $281.02M | +14.1% |
| 2018 | $246.26M | +70.1% |
| 2017 | $144.79M | +542.7% |
| 2016 | -$32.70M | -308.8% |
| 2015 | -$8.00M | -2134.4% |
| 2014 | -$358.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $148.82M | +1226.9% | +1349.7% |
| June 30, 2025 | -$11.91M | -130.3% | -162.8% |
| March 31, 2025 | $18.95M | -69.2% | -12.8% |
| December 31, 2024 | $21.73M | -87.2% | +93.7% |
| September 30, 2024 | $11.21M | -94.3% | -71.5% |
| June 30, 2024 | $39.34M | -78.4% | -36.1% |
| March 31, 2024 | $61.58M | -72.0% | -63.7% |
| December 31, 2023 | $169.76M | -35.8% | -14.0% |
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +540.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2025 period, RHYTHM PHARMACEUTICALS, INC.’s stockholders equity has grown by 38946.1% (from -$358.0 thousand to $139.07 million).
- The most recent figure is from RHYTHM PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: